Resources to advance pediatrics and HIV prevention science

The National Institute of Allergy and Infectious Diseases seeks to award multiple indefinite delivery, indefinite quantity contracts to provide preclinical development support services for candidate HIV prevention products and drug development activities through its Resources to Advance Pediatrics and HIV Prevention Science program. Offerors must propose solutions across five task areas including clinical research, nonclinical research, data management, biostatistics, and program management to be considered for awards valued between $2,500 and $98,878,757 over a seven year period of performance. Proposals will be evaluated based on offerors' experience, technical approach, and price. Proposals are due by July 7, 2022.

There is no set-aside designated for this procurement. The primary NAICS code is 541715 and PSC code R425. The place of performance will be at locations across the United States. Task orders will support activities including product discovery, pediatric formulations, and next-generation biomedical prevention tools and microbicides. The contract has a maximum total value of $98,878,757 to be awarded across multiple indefinite delivery orders from July 2023 through July 2030.